TechCrunch

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

By TechCrunch

1 min read
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Startups & Entrepreneurship

Related Insights